Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RISE-HF: RV Contractile Reserve in Heart Failure
NCT05797584Recruiting
- Sponsor
- Istituto Auxologico Italiano
- Start
- Mar 2019
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dobutamine in heart failure (HF), sponsored by Istituto Auxologico Italiano. Primary endpoints: Right ventricle volume during Dobutamine infusion at 5 minutes, Ejection fraction during Dobutamine infusion at 5 minutes and 1 more. Started Mar 2019; status: recruiting.
02
Drugs
dobutamine
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT05797584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05797584.